Fda D.i.s.c.o. Burst Edition: Fda Approval Of Fruzaqla For Adult Patients With Met...

FDA D.I.S.C.O. Burst Edition: FDA approval of Fruzaqla (fruquintinib) for adult patients with met...

U.S. Food and Drug Administration

FDA D.I.S.C.O. Burst Edition: FDA approvals of Augtyro (repotrectinib) for NTRK gene fusion-posit...

U.S. Food and Drug Administration

FDA Approval: #Fruquintinib for #ColorectalCancer

GI Oncology Now

FRESCO2 Study: FDA Approval of Fruquintinib for Refractory Colorectal Cancer

OncBrothers: Practice-Changing Cancer Discussions

FDA Approvals in GBM, Biosimilar in Breast Cancer and Gastric/GEJ Cancer, and Biomarker Assay

Dr. Strosberg on FDA Approval of Lutathera for GEP-NETs

FDA Approvals in HCC and Gastric Cancer, ODAC Panel Splits on Adjuvant RCC Treatment, and More

FDA Approvals in MSI-High Cancers, Priority Reviews in Gastric Cancer and FL, and More

CCS Oncology Mark Falvo, M.D.

CCS Oncology Videos

FDRS 2024 - Multiple Genes for Dercum's Disease?

Fat Disorders Resource Society

Marc C. Smaldone, MD, MSHP

Fox Chase Cancer Center

Dr. Smaglo Discusses the FDA Approval of TAS-102 for Gastric/GEJ Cancer

Dana-Farber Leads FDA Approval of Stomach Cancer Drug | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

FDA Approvals in Myeloma and Head and Neck Cancer, and Findings Across Several Tumor Types

mCRC: Right-Side vs Left-Side Tumors

FDA Approvals in Myeloma and ITP, Applications Accepted in Myeloma and More

Diaz Discusses the FDA Approval of Pembrolizumab for MSI-H Solid Tumors

Targeted Oncology

FDA approves new colon cancer blood test

WATE 6 On Your Side